Delivery Order SPE2DB22D1017-SPE2DB24FF3RT

Award Date 3/4/24
Potential Completion Date 3/5/24
Potential Value $1.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a potential value of $1,344.53 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The contract is valued at $7,085.94 and has a period of performance through March 22, 2024. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $6,467.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products, with a performance period through March 12, 2024. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical and medical supply products to support military treatment programs and facilities under various...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $17,156.46 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $4,388.32 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML pharmaceutical products. This award is part of Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA, which serves as the primary contract vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $3,291.24 contract is for the supply of WEGOVY 2.4 mg/0.75 mL pens to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued up to $999,999,999.00 through...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $11,772.96 and a period of performance through April 9, 2024. This award is a task order under AmerisourceBergen's existing $999,999,999.00 indefinite delivery contract with DLA, which serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. The $23,264.87 contract has a performance period through March 18, 2024. This order was placed under AmerisourceBergen's existing $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to supply pharmaceuticals and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a $2,194.16 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. This award is part of an indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued up to $999,999,999.00, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $7,049.48 firm fixed price delivery order contract to supply the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as Amerisourcebergen's primary contract vehicle for delivering pharmaceuticals and medical supplies to DLA...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF3RT
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $1,097.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, with a completion date of March 5, 2024. This award is part of a larger single-award indefinite delivery contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to provide a range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 6/3/24, 9:28 AM